Results 111 to 120 of about 43,408 (239)

An Interpretable Machine‐Learning Framework for Multi‐Endpoint Drug‐Induced Liver Injury Classification: Evaluating the Contribution of Molecular Structure

open access: yesAdvanced Computing, Volume 1, Issue 1, December 2026.
Molecular structure provides a complementary perspective on drug‐induced liver injury. Integrating 801 drugs across five DILI endpoints, our interpretable AI framework reveals endpoint‐dependent structural contributions and links predictive classification with molecular‐level interpretation, highlighting the complex interplay between clinical ...
Priya Kumari, Kunal Roy, Madhulika Gupta
wiley   +1 more source

Diagnostic Options in Graves' or Non‐Graves' Thyrotoxicosis: A Review for Clinical Practice

open access: yesClinical Endocrinology, Volume 105, Issue 6, Page 603-609, December 2026.
ABSTRACT Objective Distinguishing Graves' disease (GD) from the other causes of thyrotoxicosis is essential for appropriate management. The clinical phenotype of GD has evolved over time and is currently more heterogenous and milder than in the past. Consequently, the differential diagnosis of thyrotoxicosis is often challenging.
Lorenzo Scappaticcio   +7 more
wiley   +1 more source

Mechanisms of hepatocellular toxicity associated with dronedarone--a comparison to amiodarone

open access: yes, 2013
Dronedarone is a new antiarrhythmic drug with an amiodarone-like benzofuran structure. Shortly after its introduction, dronedarone became implicated in causing severe liver injury. Amiodarone is a well-known mitochondrial toxicant.
Blum, Kim   +6 more
core   +1 more source

Acute Liver and Renal Failure: A Rare Adverse Effect Exclusive to Intravenous form of Amiodarone

open access: yesCase Reports in Critical Care, 2016
Amiodarone is an antiarrhythmic drug which is highly effective against a wide spectrum of ventricular tachyarrhythmias making it irreplaceable in certain group of patients.
Robin Paudel   +4 more
doaj   +1 more source

Timing of Cardiac Contractility Modulation Therapy Implementation

open access: yesClinical Cardiology, Volume 49, Issue 11, November 2026.
In this retrospective registry analysis, cardiac contractility modulation (CCM) improved functional status and left ventricular ejection fraction whether implanted early or later. Implantation within 12 months after CCM‐eligible heart failure diagnosis might be associated with better survival, greater ejection‐fraction improvement, and fewer heart ...
Goekhan Yuecel   +12 more
wiley   +1 more source

Epicardial electrical heterogeneity after amiodarone treatment increases vulnerability to ventricular arrhythmias under therapeutic hypothermia

open access: yesPLoS ONE, 2023
Background Amiodarone is commonly used during therapeutic hypothermia (TH) following cardiac arrest due to ventricular arrhythmias. However, electrophysiological changes and proarrhythmic risk after amiodarone treatment have not yet been explored in TH ...
Chin-Yu Lin   +13 more
doaj  

Beyond Pigmentation: Interplay of Metabolic Profile, Carotid Intima—Media Thickness, and Fatty Liver in Vitiligo: An Age‐ and Sex‐Matched Case‐Control Study

open access: yesHealth Science Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background and Aims Vitiligo shares inflammatory and metabolic pathways with cardiovascular and hepatic steatosis. Carotid intima–media thickness (IMT) is an established marker of early subclinical atherosclerosis, whereas non‐alcoholic fatty liver disease (NAFLD) reflects hepatic involvement in chronic inflammatory and metabolic dysregulation.
Mehrdad Mozafar   +8 more
wiley   +1 more source

Subclinical Hypothyroidism after a Three-Month Course of Low-Dose Amiodarone. [PDF]

open access: yes
This case report describes a 64-year-old male who developed subclinical hypothyroidism after three months of low-dose amiodarone (100 mg/day). Routine monitoring showed a TSH increase to 44.40 mU/L with normal FT4 and FT3 levels.
Aidana Butabayeva   +11 more
core   +2 more sources

Understanding the Mortality Trends in Patients With Ventricular Arrhythmias and Cardiomyopathy: A 25‐Year Retrospective Analysis From 1999–2024

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 6, November 2026.
Central illustration depicting trends in demographics and differences in Ventricular Arrhythmias with Cardiomyopathy‐related Mortality among adults in the United States from 1999 to 2024. ABSTRACT Background Ventricular Arrhythmias (VA) associated with Cardiomyopathy (CM) continues to be the major cause of death.
Nosheen Pervaiz   +8 more
wiley   +1 more source

Amiodarone Optic Neuropathy

open access: yes, 2019
Summary •Amiodarone optic neuropathy o Amiodarone is an anti-arrhythmic used by cardiology -Amiodarone produces a toxic optic neuropathy that looks similar to non-arteritic anterior ischemic optic neuropathy (NAION) o Differentiating features between ...
Andrew G. Lee, MD; Jason Zehden
core  

Home - About - Disclaimer - Privacy